Table 1.
Variable | Patients of COVID-19 with pancreatitis |
Patients of COVID-19 with elevated
pancreatic enzymes (N = 29) |
Patients of COVID-19 without
elevated enzymes (N = 23) |
P | |||
---|---|---|---|---|---|---|---|
P1 | P2 | P3 | Overall | ||||
Age (mean) | 55 | 45 | 29 | 43 ± 13 | 63 ± 12 | 61 ± 11 | 0.18 |
Sex, male n (%) | N | Y | N | 2(66.7) | 18(62.1) | 17(73.9) | 0.72 |
Epidemiology | N | N | N | 0(0) | 0(0) | 0(0) | – |
Comorbidities, n(%) | |||||||
Hypertension | N | N | N | 0(0) | 13(44.8) | 9(39.1) | 0.41 |
Diabetes | N | N | N | 0(0) | 6(20.7) | 4(17.4) | 1 |
COPD | N | N | N | 0(0) | 0(0) | 0(0) | – |
Cardiac disease | Y | N | N | 1(33.3) | 2(6.9) | 2(8.7) | 0.37 |
Chronic Renal disease | N | N | N | 0(0) | 1(3.4) | 2(8.7) | 0.64 |
Carcinoma | N | N | N | 0(0) | 1(3.4) | 3(13) | 0.46 |
HCV | N | N | N | 0(0) | 0(0) | 0(0) | – |
HIV | N | N | N | 0(0) | 0(0) | 0(0) | – |
Hyperlipidemia | Y | N | N | 1(33.3) | 0(0) | 0(0) | 0.05 |
COPD, chronic obstructive pulmonary disease; HIV, human immunodeficiency virus; HCV, hepatitis C virus. The enrolled patients were aged between 29 and 79 years. Eighteen (32.7%) were women, the median age was 63 years and the average age was 61 years.